Full Fed. Circ. Won't Review Inventorship Row Over Cancer IP
The full Federal Circuit Friday rejected a bid from Bristol-Meyers and others for review of a panel decision that two American scientists from the Dana-Farber Cancer Institute should be named as...To view the full article, register now.
Already a subscriber? Click here to view full article